deaths (OS)

mRCC - L1 - PDL1 positive metastatic/advanced RCC (mRCC) - 1st line (L1) mRCC - L1 - PDL1 positive

versus sunitinib
atezolizumab alone vs. sunitinib 1 -
atezolizumab plus bevacizumab vs. sunitinib 2 NaN [NaN; NaN] /10000
0/0 vs. 0/0